Search Results
Aug 25, 2026, 07:47 ET Starwood Pet Travel Reports Record Demand for Portugal Pet Relocations, With Requests Up 77% Since 2022
the relocation process, from import documentation and health certificates to crate training, booking, and door-to-door logistics. Starwood is part of IVC Evidensia. Learn more at www.starwoodpet.com.Follow Starwood Pet Travel:
More news about: Starwood Pet Travel
Aug 24, 2026, 12:19 ET Carotenoids Market worth $3.52 billion by 2031- Exclusive Report by MarketsandMarkets™
Funding Context In July 2026, Kuehnle AgroSystems (KAS) secured a multi-million-dollar Series B financing led by Ichthus Venture Capital (IVC), with participation from S2G Investments, Hatch Blue, and Dest EOOD. The funding will support R&D expansion, manufacturing scale-up, regulatory
More news about: MarketsandMarkets
Jun 09, 2026, 01:07 ET DER VENENSTENT GORE® VIABAHN® FORTEGRA ERHÄLT DIE MDR-ZULASSUNG
die CE-Zulassung für den GORE®VIABAHN®FORTEGRA Venenstent bekannt, der für die Behandlung symptomatischer inferiorer Vena cava (IVC) und iliofemoraler venöser Abflussbehinderungen indiziert ist.Aufbauend auf der jüngsten FDA-Zulassung in den USA spiegelt dieser Meilenstein das Engagement
More news about: W. L. Gore & Associates GmbH
Jun 09, 2026, 01:07 ET THE GORE® VIABAHN® FORTEGRA VENOUS STENT RECEIVES MDR APPROVAL
Mark approval for the GORE® VIABAHN® FORTEGRA Venous Stent, indicated for use in the treatment of symptomatic inferior vena cava (IVC) and iliofemoral venous outflow obstruction. Building on the recent U.S. FDA approval, this milestone reflects Gore's commitment to expanding access
More news about: W. L. Gore & Associates GmbH
Jun 09, 2026, 01:07 ET LE STENT VEINEUX GORE® VIABAHN® FORTEGRA REÇOIT L'APPROBATION DU MDR
le stent veineux GORE®VIABAHN®FORTEGRA, indiqué pour le traitement de l'obstruction symptomatique de la veine cave inférieure (IVC) et de l'écoulement veineux ilio-fémoral.S'appuyant sur la récente approbation de la FDA américaine, cette étape reflète l'engagement de Gore à élargir
More news about: W. L. Gore & Associates GmbH
Mar 03, 2026, 12:00 ET RELIEF CARDIOVASCULAR REPORTS POSITIVE FIRST-IN-HUMAN DATA FOR DEVICE-BASED DECONGESTION THERAPY IN HEART FAILURE PATIENTS
valve-and-sensor implant intelligently modulates venous pressure using hemodynamic data. The system aims to actively adjust flow in the inferior vena cava (IVC), lowering venous pressure to drive durable decongestion in heart failure. An inQB8 Medical Technologies incubator company, Relief Cardiovascular, is
More news about: Relief Cardiovascular
Jan 20, 2026, 14:12 ET CGCC's 2026 Lunar New Year of the Horse Gala Successfully Held in New York
Bank New York Branch; Sunon Furniture LLC; COSCO SHIPPING (North America) Inc.; CSX,Inc; Aland Health Holding & International Vitamin Corporation (IVC); Dorsey & Whitney LLP; Chubb Group; CLB Management; King & Wood Mallesons; PetroChina International America Inc.; Greenland USA; Eccom Network
More news about: China General Chamber of Commerce - USA
Jan 06, 2026, 05:57 ET GORE GAINS FDA APPROVAL FOR FIRST DEEP VENOUS STENT INDICATED FOR THE IVC AND ILIOFEMORAL VEINS
Stent — previously known as the GORE® VIAFORT Vascular Stent — the first device for the treatment of deep venous disease in the inferior vena cava (IVC), iliac and iliofemoral veins.
More news about: W. L. Gore & Associates, Inc. MPD Division
Dec 10, 2025, 09:00 ET Deltek Announces FY 2026 Top Opportunities for Federal Contractors
unrestricted procurement from the Department of Veterans Affairs, the VA's Office of Integrated Veteran Care (IVC) plans to further streamline and enhance community care processes and services through the CCN Next Generation contract initiative.Estimated
More news about: Deltek
Nov 07, 2025, 06:57 ET GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE® VIABAHN® FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP VENOUS ILIOCAVAL OBSTRUCTION
prospective trial of its kind to include the inferior vena cava (IVC), iliac and femoral veins. All treated patients had thrombotic disease (acute, subacute, or chronic/post thrombotic syndrome), of which 94.3% had lesions spanning three vessel regions (IVC + bilateral iliofemoral veins), and 68.5% required stents
More news about: W. L. Gore & Associates, Inc. MPD Division
Nov 05, 2025, 12:05 ET A DXC inaugura seu primeiro Centro de Experiência do Cliente nas Filipinas, expandindo sua presença na Ásia para promover a colaboração e a inovação em IA
Cliente, a DXC firmou uma parceria com a Baby and Moms PH para doar laptops recondicionados a estudantes do ensino médio do Industrial Valley Complex (IVC), na cidade de Marikina, como parte do
More news about: DXC Technology Company
Nov 05, 2025, 11:54 ET DXC inaugura su primer centro de experiencia para clientes en Filipinas y amplía su presencia en Asia para impulsar la colaboración y la innovación en IA
ha asociado con Baby and Moms PH para donar dispositivos portátiles reacondicionados a los estudiantes de secundaria del Industrial Valley Complex (IVC), en la ciudad de Marikina, como parte del
More news about: DXC Technology Company
Nov 05, 2025, 10:57 ET Late-Breaking Clinical Trial Results Announced at VIVA 2025
functional assessments (eg, PVFS Scale, mMRC, Borg Scale, 6MWT). Core lab parameters included pulmonary artery (PA) obstruction index (MMS and RMMS) and IVC reflux. Clinical parameters included vital signs and National Early Warning Score 2 score (risk of clinical deterioration). The reduction in
More news about: The VIVA Foundation
Nov 05, 2025, 10:52 ET DXC eröffnet erstes Kundenerlebniszentrum auf den Philippinen und baut damit seine Präsenz in Asien aus, um Zusammenarbeit und KI-Innovation voranzutreiben
offiziellen Eröffnung des Kundenerlebniszentrums hat DXC gemeinsam mit Baby and Moms PH renovierte Laptops an Schüler des Industrial Valley Complex (IVC) in Marikina City gespendet. Die Spende ist Teil des „
More news about: DXC Technology Company
Nov 05, 2025, 10:41 ET DXC 在菲律賓開設首個客戶體驗中心，擴大亞洲業務版圖，並推動合作與人工智能創新
的 SAP 卓越中心，也是最集中該公司全球 SAP 能力與專業知識的地方。SAP 於菲律賓聘任超過 1800 名顧問，而該團隊支援全球超過 350 個企業客戶和帳戶。 DXC 已與 Baby and Moms PH 合作，向馬利金納市工業谷綜合體 (IVC) 的高中生捐贈翻新筆記型電腦，並作為客戶體驗中心正式啟用與
More news about: DXC Technology Company
Nov 05, 2025, 10:41 ET DXC ouvre son premier centre d'expérience client aux Philippines et renforce sa présence en Asie pour promouvoir la collaboration et l'innovation en matière d'IA
client, DXC s'est associé à Baby and Moms PH pour faire don d'ordinateurs portables remis à neuf aux élèves du secondaire de Industrial Valley Complex (IVC), Marikina City, dans le cadre du
More news about: DXC Technology Company
Nov 05, 2025, 10:15 ET DXC inaugura su primer Centro de Experiencia del Cliente en Filipinas
Experiencia del Cliente, DXC se asoció con Baby and Moms PH para donar portátiles reacondicionados a estudiantes de secundaria del Complejo Industrial Valley (IVC) en la ciudad de Marikina, en el marco del
More news about: DXC Technology Company
Nov 04, 2025, 09:00 ET DXC Opens First Client Experience Centre in the Philippines, Expanding Its Presence in Asia to Drive Collaboration and AI Innovation
Client Experience Centre, DXC has partnered with Baby and Moms PH to donate refurbished laptops to high school students of Industrial Valley Complex (IVC), Marikina City, as part of
More news about: DXC Technology Company
Nov 04, 2025, 09:00 ET DXC Opens First Client Experience Centre in the Philippines, Expanding Its Presence in Asia to Drive Collaboration and AI Innovation
Client Experience Centre, DXC has partnered with Baby and Moms PH to donate refurbished laptops to high school students of Industrial Valley Complex (IVC), Marikina City, as part of
More news about: DXC Technology Company
Nov 02, 2025, 18:03 ET Late-Breaking Clinical Trial Results Announced at The VEINS 2025
solutions for complex venous conditions. The VIAFORT Trial is the first prospective study to include the inferior vena cava (IVC), iliac, and femoral veins. Conducted across multiple international centers, the single-arm, non-randomized trial enrolled 89 patients with thrombotic
More news about: The VIVA Foundation
Oct 21, 2025, 00:48 ET EXEED Co-Creation Workshop: Texxeract Technology Premieres, Three New Models Debut with the New Family Design Language
certification, setting a new benchmark for NEV safety standards. Performance remains Texxeract's core highlight. Equipped with the iVC Intelligent Vehicle Control System, vehicles deliver strong power, exceptional acceleration, and top-speed performance. The EXEED ES, for example, accelerates
More news about: EXEED
Oct 20, 2025, 03:25 ET EXEED Co-Creation Workshop: Texxeract Technology Premieres, Three New Models Debut with the New Family Design Language
certification, setting a new benchmark for NEV safety standards. Performance remains Texxeract's core highlight. Equipped with the iVC Intelligent Vehicle Control System, vehicles deliver strong power, exceptional acceleration, and top-speed performance. The EXEED ES, for example, accelerates
More news about: EXEED
Oct 20, 2025, 02:31 ET EXEED Co-Creation Workshop: Texxeract Technology Premieres, Three New Models Debut with the New Family Design Language
certification, setting a new benchmark for NEV safety standards. Performance remains Texxeract's core highlight. Equipped with the iVC Intelligent Vehicle Control System, vehicles deliver strong power, exceptional acceleration, and top-speed performance. The EXEED ES, for example, accelerates
More news about: EXEED